title: Differences in O2 reduction by the iron complexes of adriamycin and daunomycin: the importance of the sidechain hydroxyl group.
authors.forename: J L
authors.initials: JL
authors.lastname: Zweier
authors.forename: L
authors.initials: L
authors.lastname: Gianni
authors.forename: J
authors.initials: J
authors.lastname: Muindi
authors.forename: C E
authors.initials: CE
authors.lastname: Myers
mesh_terms: D000693:Anaerobiosis; D004279:DNA, Viral; D003630:Daunorubicin; D004317:Doxorubicin; D004578:Electron Spin Resonance Spectroscopy; D007502:Iron Chelating Agents; D010084:Oxidation-Reduction; D010100:Oxygen; D010101:Oxygen Consumption; D013053:Spectrophotometry; D013329:Structure-Activity Relationship
chemical_list: D004279:DNA, Viral; D007502:Iron Chelating Agents; D004317:Doxorubicin; D010100:Oxygen; D003630:Daunorubicin